CORDIS
EU research results

CORDIS

English EN
New Diagnostics for Infectious Diseases: “ND4ID”

New Diagnostics for Infectious Diseases: “ND4ID”

Objective

Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid point of care (POC) in vitro diagnostics (IVD) are key tools in the effective clinical management of patients with infectious diseases. Yet there is still a large unmet clinical need for more rapid POC IVDs generating more clinically relevant, actionable information. Effectively addressing this need requires a change in the current approach in training researchers on IVDs, generating a new ‘breed’ of IVD researchers capable of closing the gap between the clinical and technological perspective. ND4ID takes up this challenge by offering 15 ESRs a world-class first of its kind training programme where they will be exposed to the full breadth of disciplines spanning clinical, technological and market-oriented viewpoints, from both the academic and non-academic sector. Through a set of synergistic research projects on novel POC assays, targeting the most important and urgent clinical needs at world leading academic or private sector research groups, the ESRs are offered a holistic training program, preparing them to be lead players in the future IVD field. This training through research is augmented by a unique comprehensive network-wide training programme covering clinical, technical and translational knowledge and skills of relevance to IVD research, development and exploitation. As such, ND4ID will deliver ESRs that will be in high demand serving as an example for other academic and non-academic actors active in training IVD researchers and further strengthening Europe’s position in the internally competitive arena of IVD technology.

Coordinator

UNIVERSITEIT ANTWERPEN

Address

Prinsstraat 13
2000 Antwerpen

Belgium

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 501 120

Participants (7)

Sort alphabetically

Sort by EU Contribution

Expand all

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU Contribution

€ 751 680

KUNGLIGA TEKNISKA HOEGSKOLAN

Sweden

EU Contribution

€ 1 054 637,28

STOCKHOLMS UNIVERSITET

Sweden

EU Contribution

€ 263 659,32

AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

Spain

EU Contribution

€ 247 872,96

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

Switzerland

EU Contribution

€ 265 226,76

BIOMERIEUX SA

France

EU Contribution

€ 525 751,20

BIOCARTIS NV

Belgium

EU Contribution

€ 250 560

Partners (15)

Sort alphabetically

Expand all

UNIVERSITAIR ZIEKENHUIS ANTWERPEN

UNIVERSITEIT GENT

UNIVERSITE DE GENEVE

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

DANMARKS TEKNISKE UNIVERSITET

JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY

MICROFLUIDIC CHIPSHOP GMBH

LEWIS TREVOR STANLEY MEDICAL DEVICE CONSULTANCY

Semiotics

DOC Research bv

E-Bug

GALAPAGOS

NXP SEMICONDUCTORS NETHERLANDS BV

Project information

Grant agreement ID: 675412

Status

Ongoing project

  • Start date

    1 March 2016

  • End date

    29 February 2020

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 3 860 507,52

  • EU contribution

    € 3 860 507,52

Coordinated by:

UNIVERSITEIT ANTWERPEN

Belgium